You are here: Industry Insights > bowel

News List

Low-Residue Diet Comparable to Clear Liquid Diet for Colonoscopy Prep, More Tolerable for Patients firstwordpharma
May 26, 2021
A low-residue diet is comparable to a clear liquid diet for colonoscopy prep in regards to prep quality, and is associated with improved patient tolerability, according to a study presented at Digestive Disease Week (DDW) 2021.
FDA Approves Ibsrela (tenapanor) for the Treatment of Irritable Bowel Syndrome with Constipation drugs
September 16, 2019
Ardelyx, Inc. announced that the U.S. Food and Drug Administration has approved Ibsrela (tenapanor), a 50 mg, twice daily oral pill for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults.
Type 2 Diabetes Risk Up With Inflammatory Bowel Disease drugs
August 23, 2019
Patients with inflammatory bowel disease (IBD) have increased risk of type 2 diabetes, according to a study published online in Clinical Gastroenterology and Hepatology.
Mechanical, Oral Antibiotic Bowel Prep Yields No Benefit for Colectomy drugs
August 20, 2019
Mechanical and oral antibiotic bowel preparation (MOABP) does not reduce surgical site infections (SSIs) or the overall morbidity of colon surgery versus no bowel preparation (NBP)...
Irritable Bowel Symptoms Tied to Intestinal, Brain Abnormalities drugs
June 10, 2019
Irritable Bowel Symptoms Tied to Intestinal, Brain Abnormalities.
RedHill Biopharma enrols last patient in Phase II irritable bowel syndrome trial europeanpharmaceuticalreview
May 07, 2019
RedHill Biopharma has enrolled the last patient in the Phase II study with Bekinda for the treatment of diarrhoea-predominant irritable bowel syndrome…
Calcium supplements may boost risk of abnormal bowel growths europeanpharmaceuticalreview
April 25, 2019
Calcium supplements, taken with or without vitamin D, may increase the risk of small growths in the colon…